• United Community Banks Cut to “Hold” at Zacks Investment Research

    18 days ago - By ETF Daily News

    Zacks Investment Research downgraded shares of United Community Banks from a buy rating to a hold rating in a research note issued to investors on Tuesday morning, Zacks.com reports.
    According to Zacks, “United Community Bank is a bank holding company. United conducts its operations through a community-focused operating model of separate community banks, which, as of December 31, 2016, operated at 139 locations throughout the Atlanta-Sandy Springs-Roswell, Georgia, and Gainesville, Georgia metropolitan statistical areas, upstate and coastal South Carolina, north and coastal Georgia...
    Read more ...

     

  • Altus Midstream Rating Increased to Hold at Zacks Investment Research

    Altus Midstream Rating Increased to Hold at Zacks Investment Research

    18 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Altus Midstream from a strong sell rating to a hold rating in a research note released on Tuesday morning, Zacks.com reports.
    According to Zacks, “Altus Midstream Company is a pure-play, Permian Basin midstream C-corporation. The company or its subsidiaries own substantially all of the gas gathering, processing and transportation assets servicing Apache Corporation's production in the Alpine High play in the Delaware Basin. Altus Midstream Company, formerly known as Kayne Anderson Acquisition Corporation, is based in Houston, United States...
    Read more ...

     

  • Agora Stock Rating Lowered by Zacks Investment Research

    Agora Stock Rating Lowered by Zacks Investment Research

    18 days ago - By ETF Daily News

    Zacks Investment Research downgraded shares of Agora from a hold rating to a sell rating in a report published on Tuesday, Zacks.com reports.
    According to Zacks, “Agora, Inc. provides Real-Time Engagement Platform-as-a-Service principally in the People's Republic of China, the United States and internationally. Its RTE-PaaS offers developers with software tools to embed real-time video, voice, and messaging functionalities into their applications. Agora, Inc. is based in Shanghai, China. “
    Other research analysts have also recently issued reports about the company. Barclays upped their...
    Read more ...

     

  • Arcturus Therapeutics Lifted to “Hold” at Zacks Investment Research

    Arcturus Therapeutics Lifted to “Hold” at Zacks Investment Research

    18 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Arcturus Therapeutics from a sell rating to a hold rating in a research note issued to investors on Tuesday morning, Zacks.com reports.
    According to Zacks, “Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as Alcobra Ltd, is based in San Diego, CA. “
    A number of other research firms also recently issued...
    Read more ...

     

  • AST SpaceMobile Lowered to Sell at Zacks Investment Research

    AST SpaceMobile Lowered to Sell at Zacks Investment Research

    18 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of AST SpaceMobile from a hold rating to a sell rating in a report published on Tuesday, Zacks.com reports.
    According to Zacks, “AST SpaceMobile is building space-based cellular broadband network to operate directly with standard, unmodified mobile devices based on its extensive IP and patent portfolio. AST SpaceMobile, formerly known as New Providence Acquisition Corp., is based in Texas, United States. “
    AST SpaceMobile stock opened at $7.41 on Tuesday. AST SpaceMobile has a fifty-two week low of $6.96 and a fifty-two week high of $25.37. The...
    Read more ...

     

  • Aurinia Pharmaceuticals Downgraded by Zacks Investment Research

    Aurinia Pharmaceuticals Downgraded by Zacks Investment Research

    18 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of Aurinia Pharmaceuticals from a hold rating to a sell rating in a research report released on Tuesday, Zacks.com reports.
    According to Zacks, “Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada. “
    Other research analysts have also issued research reports about the company. HC Wainwright boosted their...
    Read more ...

     

  • Zacks Investment Research Upgrades Avalo Therapeutics to “Buy”

    Zacks Investment Research Upgrades Avalo Therapeutics to “Buy”

    18 days ago - By ETF Daily News

    Avalo Therapeutics was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The brokerage presently has a $2.00 price target on the stock. Zacks Investment Research ‘s price target would indicate a potential upside of 65.29% from the stock's previous close.
    According to Zacks, “Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare...
    Read more ...

     

  • Capital & Counties Properties PLC Price Target Cut to GBX 175

    Capital & Counties Properties PLC Price Target Cut to GBX 175

    18 days ago - By ETF Daily News

    Capital & Counties Properties PLC had its target price reduced by investment analysts at Morgan Stanley from GBX 185 to GBX 175 in a research note issued to investors on Wednesday, Price Targets.com reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley's price target would suggest a potential upside of 1.98% from the company's previous close.
    CAPC has been the topic of several other research reports. Barclays raised their price objective on shares of Capital & Counties Properties PLC from GBX 140 to GBX 155 and gave the company an “underweight” rating...
    Read more ...

     

  • Zacks Investment Research Lowers Daqo New Energy to Sell

    Zacks Investment Research Lowers Daqo New Energy to Sell

    18 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of Daqo New Energy from a buy rating to a sell rating in a research report released on Monday, Zacks.com reports.
    According to Zacks, “Daqo New Energy Corp. is engaged in the manufacture and sale of high-quality polysilicon to photovoltaic product manufacturers. The polysilicon is further processed into ingots, wafers, cells and modules for solar power solutions. Daqo New Energy Corp., formerly known as Mega Stand International Limited, is headquartered in Wanzhou, The People's Republic of China. “
    A number of other equities research analysts have...
    Read more ...

     

  • Zacks Investment Research Lowers Fulton Financial to Hold

    Zacks Investment Research Lowers Fulton Financial to Hold

    18 days ago - By ETF Daily News

    Zacks Investment Research lowered shares of Fulton Financial from a buy rating to a hold rating in a research note published on Monday morning, Zacks.com reports.
    According to Zacks, “Fulton Financial Corp. is a bank holding company. It provides retail and commercial banking and investment management and trust services in central and eastern Pennsylvania, southern New Jersey, northern Maryland and southern Delaware through its wholly-owned subsidiaries: Fulton Bank, Lebanon Valley Farmers Bank, Swineford National Bank, Lafayette Ambassador Bank, FNB Bank, N.A., Great Valley Bank...
    Read more ...

     

  • Andritz Lifted to Hold at Zacks Investment Research

    Andritz Lifted to Hold at Zacks Investment Research

    18 days ago - By ETF Daily News

    Zacks Investment Research upgraded shares of Andritz from a sell rating to a hold rating in a research report released on Tuesday, Zacks.com reports.
    According to Zacks, “Andritz AG is engages in the provision of plants, equipment and services for hydropower stations. Its operating segment consists of Hydro; Pulp & Paper; Metals and Separation. Hydro segment installs and offers electromechanical systems, pumps and hydropower equipment. Pulp & Paper segment manufactures and trades tissue, board and paper products. Metals segment processes cold-rolled carbon steel, metal strip and stainless...
    Read more ...

     

  • Fortis Rating Lowered to Neutral at UBS Group

    Fortis Rating Lowered to Neutral at UBS Group

    18 days ago - By ETF Daily News

    Fortis was downgraded by equities researchers at UBS Group from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, Price Targets.com reports. They currently have a C$61.00 price target on the stock. UBS Group's target price would suggest a potential upside of 2.62% from the stock's current price.
    A number of other research firms have also recently weighed in on FTS. Veritas Investment Research decreased their price objective on shares of Fortis to C$58.00 and set a “na” rating for the company in a research report on Friday, December 3rd. CSFB upped their...
    Read more ...

     

  • Erasca Raised to Hold at Zacks Investment Research

    Erasca Raised to Hold at Zacks Investment Research

    18 days ago - By ETF Daily News

    Erasca was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports.
    According to Zacks, “Erasca Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Erasca Inc. is based in SAN DIEGO. “
    Separately, Guggenheim decreased their price target on shares of Erasca from $25.00 to $20.00 in a research note on Monday. Two analysts have rated the stock with a hold rating and four have given a buy rating...
    Read more ...

     

  • AAR Upgraded to B- at TheStreet

    AAR Upgraded to B- at TheStreet

    18 days ago - By ETF Daily News

    TheStreet upgraded shares of AAR from a c+ rating to a b- rating in a report released on Tuesday, TheStreetRatingsTable reports.
    Other research analysts have also recently issued reports about the company. Vertical Research upgraded AAR from a hold rating to a buy rating in a research note on Tuesday. Royal Bank of Canada initiated coverage on AAR in a research note on Thursday, October 21st. They set an outperform rating and a $45.00 price target on the stock. Finally, Citigroup upgraded AAR from a sell rating to a neutral rating in a research note on Monday. One analyst has rated the...
    Read more ...

     

  • Citizens & Northern Rating Increased to Buy at Zacks Investment Research

    Citizens & Northern Rating Increased to Buy at Zacks Investment Research

    18 days ago - By ETF Daily News

    Citizens & Northern was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Zacks.com reports. The brokerage currently has a $29.00 price target on the financial services provider's stock. Zacks Investment Research ‘s price target would indicate a potential upside of 8.53% from the company's current price.
    According to Zacks, “Citizens & Northern Corporation is a one-bank holding company whose principal subsidiary is Citizens & Northern Bank. The Corporation's principal office is located in Wellsboro...
    Read more ...

     

  • Eyenovia Rating Increased to Buy at Zacks Investment Research

    Eyenovia Rating Increased to Buy at Zacks Investment Research

    18 days ago - By ETF Daily News

    Eyenovia was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Zacks.com reports. The firm presently has a $4.25 target price on the stock. Zacks Investment Research ‘s price target would indicate a potential upside of 18.38% from the company's previous close.
    According to Zacks, “Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and...
    Read more ...

     

  • FormFactor Trading Up 6.2% Following Analyst Upgrade

    FormFactor Trading Up 6.2% Following Analyst Upgrade

    18 days ago - By ETF Daily News

    FormFactor, Inc. shot up 6.2% during trading on Thursday after Needham & Company LLC raised their price target on the stock from $45.00 to $54.00. Needham & Company LLC currently has a buy rating on the stock. FormFactor traded as high as $45.36 and last traded at $45.36. 4,633 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 338,491 shares. The stock had previously closed at $42.73.
    In other FormFactor news, CEO Mike Slessor sold 25,000 shares of the business's stock in a transaction dated Friday, November 5th. The stock was sold at an...
    Read more ...

     

  • UBS Group Initiates Coverage on Cyxtera Technologies

    UBS Group Initiates Coverage on Cyxtera Technologies

    18 days ago - By ETF Daily News

    UBS Group assumed coverage on shares of Cyxtera Technologies in a research note published on Monday, PriceTargets.com reports. The brokerage issued a neutral rating and a $14.00 price objective on the stock.
    “ context”:”http:\/\/schema.org”,” type”:”Article”,”headline”:”Cyxtera Technologies initiated with a Neutral at UBS”,”image”:”https:\/\/thefly.com\/images\/logo thefly small.png”,”datePublished”:”2022-01-03T05:49:33-0500″,”description”:”Article symbols: CYXT”}Cyxtera Technologies initiated with a Neutral at UBS CYXT - The Fly Algunos plugins generan llamados a undefined page siempre...
    Read more ...

     

  • Zacks Investment Research Upgrades Fulton Financial to Buy

    Zacks Investment Research Upgrades Fulton Financial to Buy

    18 days ago - By ETF Daily News

    Fulton Financial was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Zacks.com reports. The brokerage presently has a $20.00 price target on the bank's stock. Zacks Investment Research ‘s price objective points to a potential upside of 9.65% from the stock's previous close.
    According to Zacks, “Fulton Financial Corp. is a bank holding company. It provides retail and commercial banking and investment management and trust services in central and eastern Pennsylvania, southern New Jersey, northern Maryland and southern Delaware...
    Read more ...

     

  • Industrial Logistics Properties Trust Stock Rating Upgraded by Zacks Investment Research

    Industrial Logistics Properties Trust Stock Rating Upgraded by Zacks Investment Research

    18 days ago - By ETF Daily News

    Industrial Logistics Properties Trust was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. The firm presently has a $29.00 price target on the stock. Zacks Investment Research ‘s price target suggests a potential upside of 15.58% from the stock's current price.
    According to Zacks, “Industrial Logistics Properties Trust is focused on the ownership and leasing of industrial and logistics properties primarily in the United States. The Company's properties include Hawaii...
    Read more ...